Company Filing History:
Years Active: 1997
Title: Mark Jeffrey Hickey: Innovator in Mycobacterial Research
Introduction
Mark Jeffrey Hickey is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of microbiology, particularly in the development of methods for quantifying bacteria. His innovative approach has implications for both in vivo and in vitro studies.
Latest Patents
Hickey holds a patent for "Mycobacterial reporter strains and uses thereof." This invention relates to a method of quantifying bacteria using bacterial reporter strains. Specifically, it provides a method utilizing mycobacterial reporter strains that allows for rapid screening of in vivo antimycobacterial activity of various compositions. The invention also includes mycobacterial reporter strains expressing the FFlux gene at levels high enough to enable detection in tissue homogenates without the need for lysis or concentration of the bacteria. He has 1 patent to his name.
Career Highlights
Mark Jeffrey Hickey is associated with Pathogenesis Corporation, where he applies his expertise in microbiology to advance research and development. His work has been instrumental in enhancing the understanding of mycobacterial infections and potential treatments.
Collaborations
Hickey collaborates with Charles K Stover, contributing to the innovative research environment at Pathogenesis Corporation. Their combined efforts aim to push the boundaries of microbiological research.
Conclusion
Mark Jeffrey Hickey's contributions to the field of microbiology through his patented inventions highlight his role as an innovator. His work continues to influence the understanding and treatment of mycobacterial infections.